Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma

Journal of Pathology

Volumn 178, Issue 2, 1996, Pages 140-145

  Vaidya, Pradeep ^a   Kawarada, Yoshifumi ^a   Higashiguchi, Takashi ^a   Yoshida, Toshimichi ^a   Sakakura, Teruyo ^a   Yatani, Ryuichi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

c erbB 2; c erbB 3; EGFR; Ki 67 antigen; Periampullary carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY KI 67; PROTEIN C ERB; UNCLASSIFIED DRUG;

ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PRIORITY JOURNAL; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; AMPULLA OF VATER; BILE DUCT NEOPLASMS; CELL DIVISION; COMMON BILE DUCT NEOPLASMS; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RECEPTORS, GROWTH FACTOR; TREATMENT OUTCOME;

EID: 0030025372     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199602)178:2<140::AID-PATH450>3.0.CO;2-U     Document Type: Article

References (29)

1. Yamaguchi K, Enjoji M. Ampullary carcinoma in patients under 50 years of age with a poor prognosis. J Surg Oncol 1990; 45: 201-206.
2. Forrest JF, Longmire WP. Carcinoma of the pancreas and periampullary region. Ann Surg 1979, 189: 129-138.
3. Cameron JL. Crist DW, Sitzmann V, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161 120-125.
4. DiGiuseppe JA, Hruban RH, Offerhaus GJA, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient With a family history of pancreatic carcinoma. Am J Pathol 1994; 144: 889-895,
5. Smit VTHB, Boot AJ, Smits AMM. Fleuren GJ. Cornelisse CJ, Bos JL. KRAS codon 12 mutations occur very frequently in pancreatic adenocarci-noma. Nucleic Acids Res 1988; 16: 7773-7782.
6. Scarpa A, Capelli P, Mukai K, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993; 142: 1534-1543.
7. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991, 64: 1076-1082.
8. Lemoine NR, Hughes CM, Barton CM, et al. The epidermal growth factor receptor in human pancreatic cancer. J Pathol 1992; 166: 7-12
9. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR. The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 1990; 161: 195-200.
10. Lemoine NR, Lobresco M, Lcung H, et al The erbB-3 gene in human pancreatic cancer. J Pathol 1992; 168: 269 273.
11. Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analvsis of mutations in Kirsten-ras oncogene. Ann Surg 1991, 214: 657-662.
12. crbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 1993; 90: 1746-1750.
13. Berger MS, Gullick WJ, Greenfield C, Evans S, Addis BJ, Waterfield MD. Epidermal growth factor receptors in lung tumours. J Pathol 1987, 152: 297-307.
14. Gusterson B, Cowley G, Mcllhinney J, Ozanne B, Fisher C, Reeves B. Evidence for increased epidermal growth factor receptors in human sarcomas Br J Cancer 1985; 36: 689-693.
15. !5. Wright C, Angus B, Nicholson S, et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 1989; 49: 2087-2090.
16. Berchuck A, Kamel A, Whitaker R, et al. Overexpression of HER-2 neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990; 50:4087-4091.
17. Yonemura Y, Ninomiya I, Yamaguchi A, et al. Evaluation of immuno-reactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 1991; 51: 1034-1038.
18. Poller DN, Spendlove I, Baker C, et al Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas. J Pathol 1992, 168: 275-280.
19. Shin RW, Iwaki T, Kitamoto T, Tateishi J. Methods in laboratory investigation: hydrated autoclave pretreatment enhances TAU immunore-actwity in formalin-fixed normal and Alzheimer's disease brain tissues Lab Invest 1991; 64: 693-702.
20. Cerny T, Barnes DM, Hasleton P, et al. Expression of epidermal growth factor receptor (EGF-R) in human lung tumors Br J Cancer 1986, 54: 265-269.
21. Tuzi NL, Venter DJ. Kumar S. Staddon SL, Lemoine NR, Gullick WJ. Expression of growth factor receptors in human brain tumours. Br J Cancer 1991, 63: 227-233
22. Henzen-Logmans SC, Fieret EJH, Berns MJJ, van der Burg EL, Klijn JGM, Foekens JA. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D Int J Cancer 1994; 57: 468-472.
23. Schlessinger J, Ullrich A. Growth factor signalling by receptor tyrosine kinases. Neuron 1992, 9: 383-391.
24. Pusztai L. Lewis CE, Lorenzen J, McGee JO'D. Growth factors' regulation of normal and neoplastic growth. J Pathol 1993, 169: 191-201
25. Gerdes J. Schwab U, Kemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
26. Gerdes J, Lemke H, Baisch H. Wacker H-H, Schwab U, Stem H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
27. Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA The clinical significance of epidermal growth-factor receptor (EGFR) in human breast cancer: a review on 5232 patients. Endocrine Rev 1992; 13: 3-17.
28. McCormick F. How receptors turn ras on. Nature 1993, 363: 15-16.
29. Feig LA. The many roads that lead to ras. Science 1993; 260: 767-768